Related references
Note: Only part of the references are listed.Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy
Aditi Pandya Martin et al.
CANCER BIOLOGY & THERAPY (2010)
Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24
Sujit K. Bhutia et al.
CANCER RESEARCH (2010)
Platonin induces autophagy-associated cell death in human leukemia cells
Yu-Jen Chen et al.
AUTOPHAGY (2009)
Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line
Pascal Colosetti et al.
AUTOPHAGY (2009)
Coordinate regulation of autophagy and apoptosis in T cells by death effectors FADD or foundation
Bryan D. Bell et al.
AUTOPHAGY (2009)
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib
Kohji Noguchi et al.
CANCER SCIENCE (2009)
RIP Kinases at the Crossroads of Cell Death and Survival
Wim Declercq et al.
CELL (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2009)
A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
Tanios Bekaii-Saab et al.
CLINICAL CANCER RESEARCH (2009)
A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1
Jianrong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
K. A. Olaussen et al.
ONCOGENE (2009)
Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells
Yu-Chuen Huang et al.
TOXICOLOGY IN VITRO (2009)
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Daniel J. Klionsky et al.
AUTOPHAGY (2008)
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison
Simone Boehrer et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer
Vincenzo Pitini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gefitinib potentiates myeloid cell differentiation by ATRA
M. B. Miranda et al.
LEUKEMIA (2008)
Bcr-Abl induces autocrine IGF-1 signaling
A. Lakshmikuttyamma et al.
ONCOGENE (2008)
Lapatinib: A sword with two edges
Laszlo Kopper
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Erlotinib exhibits antineoplastic off-target effects in AML and MDS:: a preclinical study
Simone Boehrer et al.
BLOOD (2008)
Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in K562 cells
Claudio M. Fader et al.
TRAFFIC (2008)
Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia
M. Ravindranathan et al.
LEUKEMIA (2007)
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines
D. W. Rusnak et al.
CELL PROLIFERATION (2007)
Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non-small-cell lung cancer
Geoffrey Chan et al.
BLOOD (2007)
Regulation of autophagy by NFκB transcription factor and reactives oxygen species
Mojgan Djavaheri-Mergny et al.
AUTOPHAGY (2007)
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: An update of recent developments
Neeltje Steeghs et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling
Rita Nahta et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A case of acute promyelocytic leukemia during gefitinib treatment
Daisuke Ennishi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Her2-targeted therapies in non-small cell lung cancer
Charles Swanton et al.
CLINICAL CANCER RESEARCH (2006)
Multivesicular bodies and autophagy in erythrocyte maturation
Claudio M. Fader et al.
AUTOPHAGY (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis
YF Zhou et al.
CANCER RESEARCH (2006)
Comparing antibody and small-molecule therapies for cancer
Kohzoh Imai et al.
NATURE REVIEWS CANCER (2006)
Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells
R Nahta et al.
CANCER RESEARCH (2005)
Gefitinib induces myeloid differentiation of acute myeloid leukemia
K Stegmaier et al.
BLOOD (2005)
Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
WL Xia et al.
ONCOGENE (2005)
Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells
JD Spengeman et al.
CELL CYCLE (2005)
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
L Yu et al.
SCIENCE (2004)
Differentiation therapy
AI Spira et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
GTP-mediated differentiation of the human K562 cell line: transient overexpression of GATA-1 and stabilization of the gamma-globin mRNA
F Morceau et al.
LEUKEMIA (2000)
Share Paper
